31 reports

  • Forces driving competition in the healthcare providers sector in Norway, 2019
  • Norway healthcare providers sector category segmentation: % share, by value, 2019

Table ##: Norway healthcare providers sector value: $ billion, 2015-## Figure ##: Norway healthcare providers sector value: $ billion, 2015-## ##.

  • Health Care Provider
  • Healthcare
  • Norway
  • Market Size
  • Roche Group

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies.

  • Healthcare
  • Pharmaceutical
  • Norway
  • Demand
  • Market Size
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: SECURITY HARDWARE &
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: INFRASTRUCTURE SERVICES, USD

Within the body of this report Kable present the market size and forecast spending trends for the sector which covers: TABLE ##: CATEGORY DEFINITIONS Domain Category Definition cards are now almost always built into PCs as a standard.

  • Healthcare
  • ICT
  • Norway
  • Market Segment
  • Market Size
  • Norway - Main Institutions of Social Security System ......................................................................................................................... 19
  • Norway - Main Institutions of Social Security System

This is regulated by Parliament as of May ## every year.

  • Healthcare
  • Medical Benefit
  • Pension
  • Norway
  • Economy
  • 12/14/2017: BERGENBIO TO PRESENT RECENT HIGHLIGHTS FROM ITS CLINICAL TRIALS WITH SELECTIVE AXL INHIBITOR BGB324 AT DNB'S 8TH ANNUAL NORDIC HEALTHCARE CONFERENCE
  • JUN 26, 2017: BERGENBIO AWARDED NOK 24M FROM INNOVASJON NORGE TO SUPPORT THE CLINICAL DEVELOPMENT OF BGB324 IN COMBINATION WITH KEYTRUDA FOR ADVANCED LUNG CANCER

The company' s deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Salicylic Acid
  • Targeted Therapy
  • Norway
  • Merck & Co., Inc.

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Healthcare
  • Norway
  • Company Financials
  • M&A
  • Weifa

The company' s deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Norway
  • Demand
  • Supply
  • Vistin Pharma AS
  • NATTOPHARMA ASA, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • Deal Rationale

GlobalData Nattopharma ASA, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Norway
  • Company
  • M&A
  • NattoPharma USA, Inc.
  • HEALTHCARE SYSTEM
  • NATIONAL INSURANCE SCHEME

Alliance Healthcare Norge performs this role at present (since ## January 2015 and until ## January 2019 - see ' Price Build Up: Wholesalers' ).

  • Healthcare
  • Hospital
  • Pharmacy
  • Therapy
  • Norway
  • Forecast
  • 10.3 Norway Self-Monitoring of Blood Glucose (SMBG) Market and

TABLE ##-##: WORLDWIDE: PER CAPITA HEALTHCARE SPENDING (US$), 2005 - 2012 ##.

  • Diabetes Monitoring
  • Healthcare
  • Northern Europe
  • Norway
  • Forecast
  • Weifa Raises USD18 Million in Private Placement of Shares

Weifa AS, Pharmaceuticals & Healthcare, Key Facts Web Address Revenue (US$ million) Number of Employees www. weifa. no NA ## GlobalData Key Facts Company Snapshot Company Overview Financial Deals Landscape Weifa AS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD ##

  • Healthcare
  • Pharmaceutical
  • Norway
  • M&A
  • Weifa

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Norway

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Norway

GlobalData Vaccibody AS, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Clinical Trial
  • Healthcare
  • Pharmaceutical
  • Vaccine
  • Norway

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Norway
  • Genetic Analysis AS, Pharmaceuticals & Healthcare, Deal Details
  • GENETIC ANALYSIS ENTERS INTO AGREEMENT WITH BIO-RAD LABS

GlobalData Genetic Analysis AS' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Norway
  • United States
  • Deals & Alliance
  • DIAGENIC ASA, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • DIAGENIC RAISES USD8 MILLION IN RIGHTS OFFERING OF SHARES

GlobalData DIAGENIC ASA, PHARMACEUTICALS & HEALTHCARE DEALS BY TYPE, 2012 TO YTD 2018 Deal Type Equity Offerings Divestiture - Assets No. of Deals ## ## Deal Value (US$ million) ##. ## NA DiaGenic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 DI

  • Diagnostics
  • Healthcare
  • Norway
  • Deals & Alliance
  • DiaGenic ASA
  • University of Oslo, Pharmaceuticals & Healthcare, Deal Details
  • University of Oslo, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

## ## ## ## ## ## ## ## ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA NA NA NA NA NA NA NA NA NA Oncology Ophthalmology Other Diseases Pharmaceuticals and Healthcare Respirator

  • Healthcare
  • Pharmaceutical
  • Norway
  • Deals & Alliance
  • Targovax ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

It was also under development for the treatment of cancer in combination with TG-##, CPI synergy and PD-##.

  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • Norway
  • Company
  • VENTURE FINANCING

GlobalData Nordic Nanovector ASA' s, deal volume decreased from five pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Lymphoma
  • Salicylic Acid
  • Norway
  • Company
  • Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deal Details

## ## ## ## ## ## ## ## ## ## ## Deal Value (US$ million) ##. ## NA NA NA NA NA NA NA NA NA NA NA Mouth And Dental Disorders Musculoskeletal Oncology Ophthalmology Other Diseases Pharmaceuticals and Healthcare Res

  • Health Services
  • Healthcare
  • Pharmaceutical
  • Norway
  • Social Conditions

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Norway

Wipes in Norway

800 990 650

This may also lead to opportunities for innovation in retail and away-from-home products as consumers remain alert to any future healthcare crises.

  • Healthcare
  • Medical Equipment
  • Norway
  • Demand
  • DIAGENIC ASA, MEDICAL EQUIPMENT, DEAL DETAILS
  • PARTNERSHIPS

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Healthcare
  • Medical Device
  • Norway
  • Deals & Alliance
  • DiaGenic ASA
  • PARTNERSHIPS

GlobalData offers comprehensive geographic coverage across world' s most important sectors, focusing particularly on energy and healthcare.

  • Healthcare
  • Medical Equipment
  • Medical Supply
  • Norway
  • Deals & Alliance
  • PRIVATE EQUITY
  • EQUITY OFFERING

The company offers partnership for inventors, entrepreneurs, patients, healthcare professionals and companies.

  • Healthcare
  • Medical Device
  • Medical Supply
  • Norway
  • Deals & Alliance

GlobalData offers comprehensive geographic coverage across world' s most important sectors, focusing particularly on energy and healthcare.

  • Healthcare
  • Medical Supply
  • Norway
  • Deals & Alliance
  • RayBiotech, Inc.
  • Industry
  • DEAL IN BRIEF

Pharmaceuticals and Healthcare--> Medical Devices and Diagnostics Pharmaceuticals and Healthcare--> Pharmaceuticals ## Hague Road Indianapolis Indiana United States www. roche-diagnostics. us ## ## ## 2000 Roche Holding AG is a research-focused healthcare com

  • Healthcare
  • Norway
  • Corporate Finance
  • M&A
  • Seegene, Inc.
  • DIAGENIC ASA, KEY FACTS CORPORATE ADDRESS
  • FEB 20, 2014: DIAGENIC: REPORT FROM FOURTH QUARTER 2013

In addition to his ## years tenure at DiaGenic he has international experience from several positions within finance at GE Healthcare.

  • Dementia
  • Healthcare
  • Norway
  • Company
  • DiaGenic ASA
  • DEAL REPORT: DIAGENIC SIGNS AGREEMENT WITH GE HEALTHCARE FOR BLOOD-BASED TEST
  • PARTNERSHIP

PHARMACEUTICALS AND HEALTHCARE--> HEALTHCARE--> HEALTHCARE FACILITIES AND PROVIDERS--> MEDICAL AND DIAGNOSTIC LABORATORIES ## LAVRIOU AVENUE, GLYKA NERA ATHENS GREECE WWW. GENEKOR. COM PRIVATE PARTNER ##: GENEKOR S. A.

  • Healthcare
  • Norway
  • Company
  • Corporate Finance
  • M&A